Core Historical Financial Ratios

CLB Stock  USD 20.28  0.72  3.68%   
Core Laboratories is presently reporting on over 115 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0022, PTB Ratio of 6.42 or Days Sales Outstanding of 89.98 will help investors to properly organize and evaluate Core Laboratories financial condition quickly.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Core Financial Ratios Analysis

Core LaboratoriesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Core Laboratories investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Core financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Core Laboratories history.

Core Laboratories Financial Ratios Chart

At present, Core Laboratories' Price To Sales Ratio is projected to slightly decrease based on the last few years of reporting. The current year's PTB Ratio is expected to grow to 6.42, whereas Dividend Yield is forecasted to decline to 0.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Core Laboratories stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Core Laboratories sales, a figure that is much harder to manipulate than other Core Laboratories NV multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Core Laboratories NV dividend as a percentage of Core Laboratories stock price. Core Laboratories dividend yield is a measure of Core Laboratories stock productivity, which can be interpreted as interest rate earned on an Core Laboratories investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Earnings Yield

The inverse of the price-to-earnings ratio, representing the percentage of each dollar invested in the stock that was earned by the company.
Most ratios from Core Laboratories' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Core Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
At present, Core Laboratories' Price To Sales Ratio is projected to slightly decrease based on the last few years of reporting. The current year's PTB Ratio is expected to grow to 6.42, whereas Dividend Yield is forecasted to decline to 0.
 2021 2022 2023 2024 (projected)
Dividend Yield0.0017870.0019730.0022660.002153
Price To Sales Ratio2.181.921.622.7

Core Laboratories fundamentals Correlations

0.110.07-0.50.010.020.720.270.071.00.730.580.840.57-0.740.160.290.50.390.560.57-0.8-0.19-0.190.420.09
0.11-0.08-0.430.060.370.160.03-0.080.140.150.060.310.15-0.420.380.37-0.21-0.19-0.040.69-0.37-0.44-0.40.06-0.02
0.07-0.080.040.66-0.16-0.010.211.00.05-0.020.20.050.14-0.02-0.360.06-0.10.180.24-0.10.030.110.29-0.250.93
-0.5-0.430.040.01-0.24-0.6-0.160.04-0.54-0.59-0.42-0.64-0.30.72-0.57-0.38-0.47-0.09-0.38-0.370.670.390.490.10.09
0.010.060.660.01-0.57-0.120.090.660.01-0.140.0-0.220.140.19-0.51-0.08-0.010.50.080.040.240.450.47-0.080.64
0.020.37-0.16-0.24-0.570.510.45-0.160.020.510.530.430.37-0.510.530.660.08-0.80.440.0-0.53-0.93-0.53-0.14-0.04
0.720.16-0.01-0.6-0.120.510.7-0.010.711.00.930.850.88-0.780.320.710.71-0.120.910.22-0.8-0.56-0.320.190.17
0.270.030.21-0.160.090.450.70.210.250.690.860.450.85-0.28-0.130.710.64-0.460.85-0.2-0.31-0.370.05-0.030.43
0.07-0.081.00.040.66-0.16-0.010.210.05-0.020.20.050.14-0.02-0.360.06-0.10.180.24-0.10.030.110.29-0.250.93
1.00.140.05-0.540.010.020.710.250.050.730.560.850.55-0.750.20.280.490.40.540.59-0.81-0.2-0.230.40.06
0.730.15-0.02-0.59-0.140.511.00.69-0.020.730.920.860.87-0.780.330.690.7-0.110.90.22-0.81-0.56-0.320.210.16
0.580.060.2-0.420.00.530.930.860.20.560.920.730.9-0.630.130.730.69-0.260.97-0.01-0.68-0.54-0.160.00.38
0.840.310.05-0.64-0.220.430.850.450.050.850.860.730.66-0.880.410.540.47-0.010.680.51-0.89-0.51-0.440.260.13
0.570.150.14-0.30.140.370.880.850.140.550.870.90.66-0.53-0.050.70.67-0.130.90.16-0.54-0.36-0.010.320.42
-0.74-0.42-0.020.720.19-0.51-0.78-0.28-0.02-0.75-0.78-0.63-0.88-0.53-0.51-0.67-0.29-0.02-0.61-0.530.950.710.48-0.25-0.05
0.160.38-0.36-0.57-0.510.530.32-0.13-0.360.20.330.130.41-0.05-0.510.240.01-0.290.060.21-0.49-0.6-0.97-0.2-0.44
0.290.370.06-0.38-0.080.660.710.710.060.280.690.730.540.7-0.670.240.35-0.420.730.08-0.58-0.76-0.260.110.23
0.5-0.21-0.1-0.47-0.010.080.710.64-0.10.490.70.690.470.67-0.290.010.35-0.030.66-0.13-0.35-0.070.00.080.04
0.39-0.190.18-0.090.5-0.8-0.12-0.460.180.4-0.11-0.26-0.01-0.13-0.02-0.29-0.42-0.03-0.170.330.010.620.330.30.07
0.56-0.040.24-0.380.080.440.910.850.240.540.90.970.680.9-0.610.060.730.66-0.17-0.06-0.62-0.47-0.080.070.42
0.570.69-0.1-0.370.040.00.22-0.2-0.10.590.22-0.010.510.16-0.530.210.08-0.130.33-0.06-0.54-0.15-0.250.54-0.08
-0.8-0.370.030.670.24-0.53-0.8-0.310.03-0.81-0.81-0.68-0.89-0.540.95-0.49-0.58-0.350.01-0.62-0.540.70.47-0.20.0
-0.19-0.440.110.390.45-0.93-0.56-0.370.11-0.2-0.56-0.54-0.51-0.360.71-0.6-0.76-0.070.62-0.47-0.150.70.590.060.05
-0.19-0.40.290.490.47-0.53-0.320.050.29-0.23-0.32-0.16-0.44-0.010.48-0.97-0.260.00.33-0.08-0.250.470.590.140.34
0.420.06-0.250.1-0.08-0.140.19-0.03-0.250.40.210.00.260.32-0.25-0.20.110.080.30.070.54-0.20.060.14-0.07
0.09-0.020.930.090.64-0.040.170.430.930.060.160.380.130.42-0.05-0.440.230.040.070.42-0.080.00.050.34-0.07
Click cells to compare fundamentals

Core Laboratories Account Relationship Matchups

Core Laboratories fundamentals Accounts

201920202021202220232024 (projected)
Price To Sales Ratio2.52.422.181.921.622.7
Dividend Yield0.05840.01060.0017870.0019730.0022660.002153
Ptb Ratio9.1715.66.384.973.676.42
Days Sales Outstanding71.8762.3275.1679.6888.1189.98
Book Value Per Share4.111.73.54.084.922.64
Operating Cash Flow Per Share2.021.30.80.540.530.5
Stock Based Compensation To Revenue0.03120.01520.04060.01580.02740.019
Capex To Depreciation0.990.570.730.60.671.18
Pb Ratio9.1715.66.384.973.676.42
Free Cash Flow Per Share1.521.030.50.320.30.29
Inventory Turnover10.3310.378.56.85.89.22
Net Income Per Share2.3(2.18)0.430.420.791.25
Days Of Inventory On Hand35.3335.242.9253.762.9566.1
Payables Turnover14.5517.1813.08.9612.419.98
Sales General And Administrative To Revenue0.07190.06980.09390.07780.0790.0527
Capex To Revenue0.0310.03330.02440.02880.02090.0208
Cash Per Share0.30.250.310.380.320.46
Pocfratio18.6620.3828.0637.6333.2617.66
Interest Coverage6.583.884.953.594.073.87
Payout Ratio0.96(0.13)0.0930.09530.05090.0484
Capex To Operating Cash Flow0.250.210.370.410.430.44
Pfcf Ratio24.8425.6444.5563.7258.0260.92
Days Payables Outstanding25.0821.2428.0840.7329.4233.17
Income Quality0.96(0.6)1.811.270.670.93
Ev To Operating Cash Flow22.825.7934.4245.9341.3443.4
Pe Ratio16.38(12.15)52.0348.2822.4837.57
Return On Tangible Assets0.24(0.28)0.05460.05270.07640.15
Ev To Free Cash Flow30.3632.4554.6577.7672.1175.72
Earnings Yield0.061(0.0823)0.01920.02070.04450.0322
Net Debt To E B I T D A3.11(5.54)3.653.532.842.99
Tangible Book Value Per Share(3.88)(3.27)(1.27)(0.44)2.642.78
Receivables Turnover5.085.864.864.584.143.7
Graham Number14.579.135.816.219.237.73
Shareholders Equity Per Share4.111.73.54.084.822.62

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.316
Dividend Share
0.04
Earnings Share
0.54
Revenue Per Share
11.158
Quarterly Revenue Growth
0.072
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.